Double Medical Technology Inc. (002901.SZ)
CNY 30.74
(-0.03%)
CNY 30.74
(-0.03%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.51 Billion CNY | 5.9% |
| 2022 | 1.43 Billion CNY | -28.09% |
| 2021 | 1.99 Billion CNY | 25.68% |
| 2020 | 1.58 Billion CNY | 26.21% |
| 2019 | 1.25 Billion CNY | 62.77% |
| 2018 | 772.46 Million CNY | 30.04% |
| 2017 | 594.01 Million CNY | 28.39% |
| 2016 | 462.66 Million CNY | 18.08% |
| 2015 | 391.82 Million CNY | 31.09% |
| 2014 | 298.89 Million CNY | 47.49% |
| 2013 | 202.65 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 422.56 Million CNY | 4.92% |
| 2024 Q2 | 530.07 Million CNY | 25.44% |
| 2024 Q3 | 557.94 Million CNY | 6.61% |
| 2023 Q3 | 375.79 Million CNY | 4.89% |
| 2023 Q4 | 402.75 Million CNY | 7.17% |
| 2023 Q1 | 391.37 Million CNY | 96.43% |
| 2023 FY | 1.51 Billion CNY | 5.9% |
| 2023 Q2 | 358.26 Million CNY | -8.46% |
| 2022 Q4 | 199.24 Million CNY | -51.03% |
| 2022 Q3 | 406.83 Million CNY | 2.49% |
| 2022 Q2 | 396.94 Million CNY | -7.92% |
| 2022 Q1 | 431.07 Million CNY | -37.48% |
| 2022 FY | 1.43 Billion CNY | -28.09% |
| 2021 Q4 | 689.44 Million CNY | 50.43% |
| 2021 Q3 | 458.3 Million CNY | -2.81% |
| 2021 FY | 1.99 Billion CNY | 25.68% |
| 2021 Q1 | 375.03 Million CNY | -21.38% |
| 2021 Q2 | 471.55 Million CNY | 25.74% |
| 2020 Q2 | 442.49 Million CNY | 92.13% |
| 2020 Q3 | 437.06 Million CNY | -1.23% |
| 2020 FY | 1.58 Billion CNY | 26.21% |
| 2020 Q1 | 230.3 Million CNY | -40.51% |
| 2020 Q4 | 477 Million CNY | 9.14% |
| 2019 Q2 | 325.94 Million CNY | 49.86% |
| 2019 FY | 1.25 Billion CNY | 62.77% |
| 2019 Q1 | 217.5 Million CNY | -4.22% |
| 2019 Q4 | 387.1 Million CNY | 18.47% |
| 2019 Q3 | 326.76 Million CNY | 0.25% |
| 2018 Q4 | 227.07 Million CNY | 17.58% |
| 2018 Q1 | 155.01 Million CNY | 1.77% |
| 2018 Q3 | 193.11 Million CNY | -2.1% |
| 2018 Q2 | 197.25 Million CNY | 27.25% |
| 2018 FY | 772.46 Million CNY | 30.04% |
| 2017 Q1 | 128.7 Million CNY | 8.35% |
| 2017 FY | 594.01 Million CNY | 28.39% |
| 2017 Q4 | 152.31 Million CNY | -8.03% |
| 2017 Q3 | 165.61 Million CNY | 12.38% |
| 2017 Q2 | 147.37 Million CNY | 14.51% |
| 2016 Q3 | 129.03 Million CNY | 0.0% |
| 2016 FY | 462.66 Million CNY | 18.08% |
| 2016 Q4 | 118.78 Million CNY | -7.94% |
| 2015 FY | 391.82 Million CNY | 31.09% |
| 2014 FY | 298.89 Million CNY | 47.49% |
| 2013 FY | 202.65 Million CNY | 0.0% |